In May 2017, the new three-year Strategic Development Plan of the National Technology Cluster for Life Sciences ALISEI (2017-2020) was approved.
The plan is based around global macro-trends in the life-sciences field and initiatives already developed in our country such as the National Smart Specialization Strategy 2014-2020 and the National Research Program 2015-2020, which set out the objectives, development trajectories and planning priorities needed to harmonize the entire life-sciences system (research, industry, services). The new Strategic Plan starts by defining the role of the ALISEI Cluster before setting out its technology roadmap and defining its pillars of strategic action.
In our national context, ALISEI works as a “smart” link between business requirements, institutional priorities and existing needs in terms of innovative healthcare solutions. Identifying technological trajectories takes into consideration the context of an increasingly aged population and the consequent increase in chronic diseases, the rise of pathologies requiring specific dosage or combined medications and also the social and sanitary scenario created by increased migration flows.
ALISEI’s new Strategic Plan identifies four priority macro-trajectories:
- e-health, advanced diagnostics, medical devices and minimal invasiveness.
- Biotechnology, bioinformatics and pharmaceutical development.
- Regenerative, predictive and personalized medicine.
- Nutraceutical, nutritional and functional foods.
All trajectories are fully coherent with the thematic areas identified in the National Smart Specialization Strategy (NSSS) and include the priority projects identified in the NSSS itself.
After defining these trajectories, the new Strategic Plan identifies priority action areas in relation to the growth of the national innovation ecosystem:
- Support and encourage technology transfer and enhance life-science research: here ALISEI can take action on the main problems in the system through initiatives to define and standardize shared procedures and models and by co-ordinating activities and enhancing and sharing specific competences, tools (such as databases) and networks.
- Act on the growth and sustainability of research infrastructures: here ALISEI could encourage the Ministry of Education, Universities and Research to undertake a mapping exercise updating the Italian road map on research infrastructures of European relevance and publish not only the current overall situation in terms of national research infrastructure but also identify the various existing aggregations, areas of local concentration and any duplications.
On top of these two priority areas, there are two cross-cutting actions aimed at:
- Creating a better overview and analysis of funding opportunities internationally
- Increase the visibility of ALISEI and of Italy’s innovative healthcare system on international markets.